BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33045774)

  • 21. Identification of a novel mutation in PEX10 in a patient with attenuated Zellweger spectrum disorder: a case report.
    Blomqvist M; Ahlberg K; Lindgren J; Ferdinandusse S; Asin-Cayuela J
    J Med Case Rep; 2017 Aug; 11(1):218. PubMed ID: 28784167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peroxisomal bifunctional enzyme deficiency with associated retinal findings.
    Al-Hazzaa SA; Ozand PT
    Ophthalmic Genet; 1997 Jun; 18(2):93-9. PubMed ID: 9228246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two novel PEX1 mutations in a patient with Zellweger syndrome: the first Korean case confirmed by biochemical, and molecular evidence.
    Cho SY; Chang YP; Park JY; Park HD; Sohn YB; Park SW; Kim SH; Ji S; Kim SJ; Choi EW; Kim CH; Ko AR; Paik KH; Jin DK
    Ann Clin Lab Sci; 2011; 41(2):182-7. PubMed ID: 21844578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Peroxisomal neurologic diseases and Refsum disease: very long chain fatty acids and phytanic acid as diagnostic markers].
    Molzer B; Stöckler S; Bernheimer H
    Wien Klin Wochenschr; 1992; 104(21):665-70. PubMed ID: 1282286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late-onset Zellweger spectrum disorder caused by PEX6 mutations mimicking X-linked adrenoleukodystrophy.
    Tran C; Hewson S; Steinberg SJ; Mercimek-Mahmutoglu S
    Pediatr Neurol; 2014 Aug; 51(2):262-5. PubMed ID: 25079577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neonatal seizures and severe hypotonia in a male infant suffering from a defect in peroxisomal beta-oxidation.
    Van Maldergem L; Espeel M; Wanders RJ; Roels F; Gerard P; Scalais E; Mannaerts GP; Casteels M; Gillerot Y
    Neuromuscul Disord; 1992; 2(3):217-24. PubMed ID: 1483048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Very-long-chain polyunsaturated fatty acids accumulate in phosphatidylcholine of fibroblasts from patients with Zellweger syndrome and acyl-CoA oxidase1 deficiency.
    Abe Y; Honsho M; Nakanishi H; Taguchi R; Fujiki Y
    Biochim Biophys Acta; 2014 Apr; 1841(4):610-9. PubMed ID: 24418004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two different missense mutations of PEX genes in two similar patients with severe Zellweger syndrome: an argument on the genotype-phenotype correlation.
    Havali C; Dorum S; Akbaş Y; Görükmez O; Hirfanoglu T
    J Pediatr Endocrinol Metab; 2020 Mar; 33(3):437-441. PubMed ID: 32069232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peroxisomal beta-oxidation defect with detectable peroxisomes: a case with neonatal onset and progressive course.
    Barth PG; Wanders RJ; Schutgens RB; Bleeker-Wagemakers EM; van Heemstra D
    Eur J Pediatr; 1990 Jul; 149(10):722-6. PubMed ID: 2209666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autonomous Purkinje cell axonal dystrophy causes ataxia in peroxisomal multifunctional protein-2 deficiency.
    De Munter S; Bamps D; Malheiro AR; Kumar Baboota R; Brites P; Baes M
    Brain Pathol; 2018 Sep; 28(5):631-643. PubMed ID: 29341299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reinvestigation of peroxisomal 3-ketoacyl-CoA thiolase deficiency: identification of the true defect at the level of d-bifunctional protein.
    Ferdinandusse S; van Grunsven EG; Oostheim W; Denis S; Hogenhout EM; IJlst L; van Roermund CW; Waterham HR; Goldfischer S; Wanders RJ
    Am J Hum Genet; 2002 Jun; 70(6):1589-93. PubMed ID: 11992265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developmental and pathological expression of peroxisomal enzymes: their relationship of D-bifunctional protein deficiency and Zellweger syndrome.
    Itoh M; Suzuki Y; Akaboshi S; Zhang Z; Miyabara S; Takashima S
    Brain Res; 2000 Mar; 858(1):40-7. PubMed ID: 10700594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adrenal Insufficiency in Peroxisomal Disorders: A Single Institution Case Series.
    Gagnon C; Hurst ACE; Ashraf AP
    Horm Res Paediatr; 2023; 96(4):439-445. PubMed ID: 36649687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical consequences of defects in peroxisomal beta-oxidation.
    Clayton PT
    Biochem Soc Trans; 2001 May; 29(Pt 2):298-305. PubMed ID: 11356171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zellweger syndrome: report of one case.
    Lee HF; Mak SC; Wu FW; Chi CS; Huang SC
    Acta Paediatr Taiwan; 2001; 42(1):53-6. PubMed ID: 11270189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ceramide regulates interaction of Hsd17b4 with Pex5 and function of peroxisomes.
    Zhu Z; Chen J; Wang G; Elsherbini A; Zhong L; Jiang X; Qin H; Tripathi P; Zhi W; Spassieva SD; Morris AJ; Bieberich E
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Oct; 1864(10):1514-1524. PubMed ID: 31176039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unique multifunctional HSD17B4 gene product: 17beta-hydroxysteroid dehydrogenase 4 and D-3-hydroxyacyl-coenzyme A dehydrogenase/hydratase involved in Zellweger syndrome.
    de Launoit Y; Adamski J
    J Mol Endocrinol; 1999 Jun; 22(3):227-40. PubMed ID: 10343282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterozygous mutations in
    Amor DJ; Marsh AP; Storey E; Tankard R; Gillies G; Delatycki MB; Pope K; Bromhead C; Leventer RJ; Bahlo M; Lockhart PJ
    Neurol Genet; 2016 Dec; 2(6):e114. PubMed ID: 27790638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zellweger Syndrome Disorders: From Severe Neonatal Disease to Atypical Adult Presentation.
    Cheillan D
    Adv Exp Med Biol; 2020; 1299():71-80. PubMed ID: 33417208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zellweger syndrome: first reported case in Thailand and literature review.
    Jaruratanasirikul S; Vasiknanont P; Saetung P; Mitarnun W
    Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():47-51. PubMed ID: 8629140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.